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Open access under the ElPhysalin B is a natural secosteroidal, extracted from the Solanaceae plant, Physalis angulata, and it pre-
sents immune-modulator effects on the bloodsucking bug, Rhodnius prolixus. In this work, R. prolixus
was treated with physalin B at a concentration of 1 mg/ml of blood meal (oral application), or 20 ng/
insect (applied topically) or 57 ng/cm2 of ﬁlter paper (contact treatment), and infected with Trypanosoma
cruzi Dm28c clone (2  106 epimastigotes/insect). The three types of applications signiﬁcantly decreased
the number of T. cruzi Dm28c in the gut comparing with the non-treated infected insects (controls). All
groups of infected insects treated with physalin B had higher numbers of bacterial microbiota in the gut
than the non-treated controls infected with T. cruzi. We observed that the infected physalin B insects with
topical and contact treatments had a lower antibacterial activity in the gut when compared with control
infected insects. Furthermore, infected insects with the physalin B oral treatment produced higher levels
of nitrite and nitrate in the gut than control infected insects. These results demonstrate that physalin B
decreases the T. cruzi transmission by inhibiting the parasite development in the insect vector R. prolixus.
Herein the importance of physalin B modulation on the immune system and microbiota population in
terms of parasite development and transmission are discussed.
 2012 Elsevier Ltd. Open access under the Elsevier OA license. 1. Introduction
Chagas disease is a public health concern as around 10 million
people are infected with Trypanosoma cruzi (the parasite that
causes Chagas disease) worldwide (WHO, 2012). The prevention
of Chagas disease is based on the control of the insect vector of
the parasite mainly using insecticides (Carvajal et al., 2012;
WHO, 2012). However, in the last decade, different levels of insec-
ticide resistance have been detected in certain areas (Carvajal et al.,
2012). Therefore it is important to investigate other compounds
against triatomines and the parasite to suppress the transmission
of Chagas disease.
Secosteroids, which are physalins (extracted from Physalis angu-
lata) have been investigated in our laboratory, and have demon-
strated modulation of the immune responses of triatomine
nymphs, Rhodnius prolixus, infected with parasites and bacteria.
Although insects treated with physalins B, D, F or G did not haveBioquímica e Fisiologia de
il, n. 4365, pav. 26 sl 207,
.: +55 21 3865 8184.
tro).
sevier OA license. any alterations in their development and reproduction, these sub-
stances are able to induce several modiﬁcations in the humoral and
cellular immune responses leading to increased mortalities when
R. prolixus are challenged with parasites or bacteria (Garcia et al.,
2006; Castro et al., 2008, 2009).
When R. prolixus, inoculated with Trypanosoma rangeli and/or
Enterobacter cloacae, was fed on blood containing different types
of physalins there was a decrease in the number of hemocyte
microaggregations and total hemocyte counts in the hemolymph
(Garcia et al., 2006; Castro et al., 2008), and a drastic inhibition
of hemocyte phagocytosis and microaggregation in in vitro assays
(Castro et al., 2009). Also the humoral responses were altered by
a reduction in nitric oxide production in insects treated with
physalins and challenged by T. rangeli (Garcia et al., 2006). How-
ever, only a slight decrease of lysozyme and antibacterial activities
in insects treated orally with different physalins and inoculated
with bacteria was observed (Castro et al., 2008). Interestingly,
the cellular immune inhibitory effects induced by physalin B treat-
ment of R. prolixus were eliminated when exogenous arachidonic
acid (10 lg/insect) and/or platelet activation factor (PAF) (1 lg/in-
sect) were inoculated into the hemocele of the insects or incubated
in vitro with hemocytes (Castro et al., 2009). Furthermore, the
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phospholipase A2 activities, but enhanced signiﬁcantly the platelet
activation factor-acetylhydrolase (PAF-AH) activity (Castro et al.,
2009). Phospholipase A2 is an important enzyme of eicosanoids
and PAF pathways, which are responsible for immune signaling
in insects (Garcia et al., 2009). PAF-AH is an enzyme that regulates
the production of PAF, and can consequently diminish the immune
activation controlled by this compound (Garcia et al., 2009).
In the present paper we investigated the effects of physalin B on
the survival, microbiota development, antibacterial activity and
reactive nitrogen species of R. prolixus infected with T. cruzi. We
demonstrated that the compound acted as a strong regulator of
parasite survival in the insect gut and discussed the factors related
to the development of T. cruzi in the invertebrate host.
2. Materials and methods
2.1. Ethics statement
Deﬁbrinated rabbit blood used for feeding the insects was pro-
vided by the Laboratory Animals Creation Center of Fiocruz (Cecal).
All research programs using Cecal respect the guidelines of the Eth-
ics Committee on Animal Use (Ceua) established by Fiocruz
researchers and external consultants.
2.2. Physalin preparation
Physalin B was puriﬁed from stems of dried P. angulata plants
collected in Belém do Pará, Brazil, according to Soares et al.
(2003). The concentration was determined by HPLC and had an
average range between 96% and 98% for the seco-ergostane deriv-
atives. Puriﬁed physalin B is stable at room temperature for several
months (30–33 C) dissolved in dimethylsulfoxide (DMSO, Sigma).
So a physalin B solution was prepared at a concentration of 2 mg/
mL of DMSO and kept at room temperature.
2.3. Mortality and ecdysis in infected insects
The effect of physalin B on the physiology of treated and in-
fected insects was evaluated. The insects treated with physalin B
by oral, topical and contact treatment and infected by the T. cruzi
Dm28c clone were observed for 30 days after feeding to register
mortality and alterations in the ecdysis process.
2.4. Anti-Trypanosoma cruzi in vitro assay
Epimastigotes of T. cruzi Dm28c clone are maintained in our
laboratory and grown in a brain heart infusion (BHI, DIFCO) sup-
plemented with 10% heat-inactivated fetal calf serum at 28 C.
The epimastigotes (99% purity) were obtained from the log-growth
phase and incubated with different concentrations of physalin B
(1000 lg/mL, 350 lg/mL, 250 lg/mL, 100 lg/mL, 20 lg/mL,
10 lg/mL and 1 lg/mL) at 27 C for both 3 and 24 h. We also incu-
bated the parasites with different doses of the solvent, DMSO (50%,
5% and 0.5% v/v), as a control. The number of parasites was then
counted directly in a hemocytometer chamber.
2.5. Parasite infection
Fifth-instar R. prolixus nymphs were obtained from a colony
reared and maintained in our laboratory at a relative humidity of
50–60% and at 27 ± 2 C as described by Azambuja and Garcia
(1997). Insects were starved for 20–30 days before being chosen
for experiments. During the experiments they were fed on deﬁ-
brinated rabbit blood through a membrane feeding apparatus(Garcia et al., 1984). A control group (C) was fed with blood and
DMSO (0.5 ll/mL of blood) used as the solvent, and the infected
groups (CC) with blood containing 1  107 T. cruzi Dm28c clone/
mL and with DMSO (0.5 ll/mL of blood).
Only the fully engorged insects, which fed around 250 lL of
blood (estimated by weighing the insects before and after feeding),
were used in the experiments. This amount of blood ingested cor-
responds to approximately 2.0  106 T. cruzi Dm28c epimastigotes/
infected insect. All insects were raised and maintained as previ-
ously described (Azambuja and Garcia, 1997).
To determine parasite infection in insects, the whole digestive
tract was homogenized in 1 mL of sterile phosphate buffered saline
(PBS, phosphate 0.01 M and NaCl 0.15 M, pH 7.2) and the number
of parasites was counted directly in a hemocytometer chamber. A
preliminary test of parasite infection was made with control in-
sects and physalin oral treated insects from 6 to 30 days alter feed-
ing. The infection, when established in the midgut, is more intense
from 8 to 13 days (Castro et al., 2012). In the case of the physalins
group the parasites did not succeed in maintaining the infection for
the full period of 30 days. Therefore we standardized the parasite
infection count to the early period of 8–13 days, when the infection
is higher.
2.6. Physalin B treatment
R. prolixus ﬁfth-instar nymphs were treated with physalin B by
oral feeding, topical or contact applications as described below:
2.6.1. Oral treatment
Physalin B was diluted to a ﬁnal concentration of 1 lg/mL of
blood meal, based on the results obtained in a previous research
(Castro et al., 2008, 2009). A group of insects was fed blood con-
taining physalin (represented as F) and another group was fed on
blood containing physalin B and parasites (2  106 T. cruzi
Dm28c clone/mL of blood) (FC).
2.6.2. Topical treatment
Physalin B stock was diluted in Ringer buffer (0.2 M Na2CO3,
0.2 M NaHCO3, pH 9.4) to a ﬁnal concentration of 10 lg/mL, and
2 lL was applied on the thorax of the insect. We worked with an
initial dose 10 times higher (10 lg/mL) than the oral treatment
since the application was not applied directly into the digestive
tract, and therefore the compound needed to pass through the cuti-
cle, hemocele and perimicrovillar membrane to reach the gut. After
10 min, the insects were allowed to feed on blood containing par-
asites (2  106 T. cruzi Dm28c clone/mL, FTC) or not (FT).
2.6.3. Contact treatment
Physalin B stock was diluted in Ringer buffer to a ﬁnal concen-
tration of 10 lg/mL, and 1 mL of this solution was applied onto a
ﬁlter paper (176 cm2) with a ﬁnal concentration of 57 ng/cm2.
We used the same initial dose of 10 lg/mL as used for the contact
treatment. The insects were fed with blood containing parasites
(2  106 T. cruzi Dm28c clone/mL of blood) (group FPC) or not
(FP), and were placed over the physalin B treated papers (25–30 in-
sects/176 cm2) during the whole experiment period.
2.7. T. cruzi gut adhesion
Parasites adhesion to the perimicrovillar membrane of the in-
sect vector posterior midgut is an important stage for parasite
development in the host. Therefore perimicrovillar membrane of
the treated insects was dissected and prepared in saline buffer to
count the number of parasites adhered under an optic microscope.
We used membranes of control (C) and physalin B treated orally
groups (F). The parasites, T. cruzi epimastigotes, were washed three
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of 3.0  106 cells/mL. The parasite suspension (200 lL) was incu-
bated with the perimicrovillar membrane of each insect group in-
side microtubes for 30 min at 25 C. Then the midgut preparations
were spread onto glass slides and the number of attached parasites
was counted under a microscope (Nogueira et al., 2007). A hundred
randomly chosen epithelial cells from 10 different sites of each
midgut preparation were counted. For each experimental group
10 insect midguts were used.
2.8. Microbiota – colony forming unit (CFU) assay
The microbiota of the R. prolixus digestive tract was assessed by
counting bacteria colony forming units (CFU) that grew in brain
heart infusion agar (BHI agar). The kinetics of microbiota growth
in infected and non-infected insects was investigated daily for
30 days after feeding. The results demonstrated a peak of bacteria
concentration at 8 days after feeding and a signiﬁcant difference
between infected and non-infected insects (Castro et al., 2012).
Therefore the entire digestive tract was dissected under sterile
conditions (without contact of the samples with the outside cuticle
of the insect and inside a biological safety ﬂow cabinet) eight days
after treatments and homogenized in 1 mL of sterile PBS. Samples
were then immediately transferred to ice, diluted 105, 107 or
109 with PBS, and 20 lL aliquots were spread onto BHI agar
plates, and then incubated overnight at 30 C. After this the CFUs
were counted.
2.9. Antibacterial assays – turbidometric (TB) assay
We analyzed the effects of physalin B in the anterior midgut
nine days after feeding because in our recent research (Castro
et al., 2012), the antibacterial activity is more intense in this
condition.
The TB assay was modiﬁed from Thomas et al. (1999) and
Bexﬁeld et al. (2004). Each anterior midgut dissected was placed
in a tube with 200 lL of Milli-Q water, and then it was homoge-
nized and centrifuged at 8000 g for 1 min at 4 C. Aliquots of
70 lL from supernatant were transferred into tubes containing
630 lL of Milli-Q water. They were then sterilized in 0.22 mm ster-
ile ﬁlters and frozen at20 C. The assay involved the incubation of
midgut samples with 1% peptone plus the test bacteria, Escherichia
coli k12. Control wells contained (1) bacteria, peptone and antibi-
otic [streptomycin (100 lg/mL) and ampicillin (80 lg/mL)]; (2)
bacteria and peptone; and/or (3) peptone alone. Bacteria were
grown in 20 mL tryptone soy buffer (TSB) with shaking for 17 h
at 30 C and then 100 lL of the E. coli k12 solution was transferred
to 10 mL of TSB and incubated for a further 4 h. The bacteria were
then washed in PBS and diluted in TSB to a ﬁnal concentration of
1  105 cells/mL. Fifty microliters of midgut sample were then
incubated with 10 lL of bacterial suspension in triplicate in the
wells of a sterile ﬂat-bottom, 96-well microtiter plate (Nunc, Fisher
Scientiﬁc UK, Leicestershire, UK). The optical densities were mea-
sured at 550 nm (OD550) at 37 C and read at hour intervals from
time zero for 12 h. All data points were subsequently blanked
against time zero to account for the opacity of the midgut samples
and then the E. coli k12 readings were subtracted from all sample
readings and multiplied by 100.
2.10. Nitrite and nitrate determinations
Samples for the nitrite and nitrate determinations were col-
lected in the same manner as for the antibacterial assays. The ante-
rior midgut samples dissected nine days after feeding were
homogenized in a tube with 200 lL of Milli-Q water and
centrifuged at 8000 g for 1 min at 4 C. Aliquots of 10 lL fromsupernatant were diluted in 90 lL of Milli-Q water. Nitrate and
nitrite contents of samples were determined following the manu-
facturer’s instructions using the Griess Reagent System Assay Kit
(Promega, WI, USA), and absorbance of the product was measured
at 550 nm (Moncada, 1992). Nitrite and nitrate contents were
quantiﬁed as lmoles using a range of sodium nitrate standards
and the speciﬁc activity was calculated as mg/mL of protein
concentration in the anterior midgut samples.
2.11. Protein determination
Protein content of samples was quantiﬁed with a protein assay
kit (BCA⁄ Protein Assay Reagent, Pierce, USA) using bovine serum
albumin (BSA) standards.
2.12. Statistical analyses
The results were analyzed with GraphPad Prism 5 using 1 Way
ANOVA or unpaired T test, or Mann Whitney test (nonparametric
test) depending on the data distribution and number of treatments.
Data were reported as mean ± standard error (SE) or as individual
values with medians for parasite and microbiota populations. Dif-
ferences among groups were considered not statistically signiﬁcant
when p > 0.05. Probability levels are speciﬁed in the text and ﬁgure
legends.
3. Results
3.1. Mortality and ecdysis in infected insects
The physalin B treatment by oral, topical and contact applica-
tion did not alter the physiology of the insects even when the in-
sects were challenged by T. cruzi Dm28c clone. The mortality of
all treated insects (around 9.6%) was similar to control (8.2%) dur-
ing the 30 days and no alterations in the ecdysis process were
observed.
3.2. Anti-T. cruzi in vitro assay
Experiments to investigate the direct effects of physalin B on T.
cruzi Dm28c clone culture in vitro demonstrated that the com-
pound immobilizes the parasites immediately after incubation in
concentrations higher than 350 lg/mL. The number of parasites
at a dose of 350 lg/mL did not alter (10.0 ± 0.4  106 epimastig-
otes/mL) in contrast to control (12.3 ± 0.7  106 epimastigotes/
mL; p > 0.05) but T. cruzi remained immobilized for 24 h after incu-
bation. Doses of 250 lg/mL (12.2 ± 2.6  106 epimastigotes/mL;
p > 0.05) or lower did not alter the parasite motility and survival
even after 24 h of incubation. The solvent, DMSO (50% v/v), also
did not affect the parasites (8.8 ± 1.9  106 epimastigotes/mL;
p > 0.05). In the oral treatment the insects ingested about 250 ng/
mL of physalin B which is 1000 times lower than the concentration
that did not alter the parasite survival.
3.3. Physalin B and parasite infection of insects
The T. cruzi Dm28c clone infection in insects treated orally with
physalin B was investigated (FC). The results showed low or no
parasites in the digestive tract of the insects from 8 to 30 days after
treatment and infection (not shown). It is important to note that
the counting limit of the hemocytometer is 0.25  104 cells/mL
and 72% of the samples had no parasites.
The effects of topical (FTC) and contact (FPC) treatments of phy-
salin B on the insects with parasite infection were also studied.
Eight to 13 days after treatment and parasite infection we observed
Fig. 1. Microbiota population in R. prolixus 5th-instar nymphs digestive tract 8 days
after treatment with physalin B and challenge by T. cruzi Dm28c clone. Treatments:
C – control insects fed on blood and solvent (DMSO); CC – insects treated with
solvent and infected with T. cruzi Dm28c clone; F – insects treated orally with
physalin B (1 lg/mL blood); FC – insects treated orally with physalin B (1 lg/mL
blood) and infected with T. cruzi Dm28c clone; FT – insects treated topically with
physalin B (20 ng/insect); FTC – insects treated topically with physalin B (20 ng/
insect) and infected with T. cruzi Dm28c clone; FP – insects treated by contact with
physalin B (57 ng/cm2); FPC – insects treated by contact with physalin B (57 ng/
cm2) and infected with T. cruzi Dm28c clone. Each point represents the number of
bacteria in an individual digestive tract, and horizontal lines indicate the median.
Treatments were repeated 3–5 times with 6–10 insects in each experiment
reaching a total of 25–35 insects for each group. Medians were analyzed with 1 way
ANOVA and Mann–Whitney test.
Fig. 2. Antibacterial activity in R. prolixus 5th-instar nymphs treated with physalin
B and challenged by T. cruzi Dm28c clone. Turbidometric (TB) assay of anterior
D.P. Castro et al. / Journal of Insect Physiology 58 (2012) 1620–1625 1623no signiﬁcant differences between FTC (0.3  104 parasites/mL of
digestive tract), FPC (0.7  104 parasites/mL of digestive tract),
and in insects treated orally FC (0.87  104 parasites/mL of diges-
tive tract). However, signiﬁcant differences were observed when
we compared these groups with control group (7.5  104 para-
sites/mL of digestive tract) (Table 1).
3.4. Insects treated with physalin B and in vitro adhesion of parasites
In this experiment we observed that insects treated orally with
physalin B (F) did not alter the T. cruzi Dm28c clone gut adhesion
in vitro when compared to control group (C) (not shown).
3.5. Physalin B treatments and gut microbiota
The gut microbiota in insects that received oral, topical and con-
tact treatments with physalin B was signiﬁcantly diminished when
compared to controls. The median number of bacteria in insects
treated orally with only DMSO (C) was 1.0  1011 bacteria/diges-
tive tract at 8 days after treatment. However the median number
of bacteria in the insects treated orally with physalin B (F) was
5.7  1010 (p = 0.0062) bacteria/digestive tract, treated topically
with the compound (FT) was 4.0  109 (p = 0.0001) bacteria/diges-
tive tract, and treated with physalin B by contact (FP) was
6.9  1010 (p = 0.0548) bacteria/digestive tract (Fig. 1). These re-
sults show lower microbiota for insects treated with physalin
when comparing to control (C), but only oral and topical treatment
had signiﬁcant differences (Fig. 1).
The insects treated with physalin B (oral, topical and contact)
and infected with parasites also had lower average number of bac-
teria population than control (C) but higher than infected control
(CC) (Fig. 1). The insects treated with solvent and infected (CC)
with parasites had 1.8  109 bacteria/gut while infected insects or-
ally treated with physalin B (FC) had 10 times more bacteria
(1.8  1010 bacteria/digestive tract) than control infected (CC),
(p = 0.023). Similar results were observed in physalin B by topical
application and infected (FTC) (1.5  1010 bacteria/gut)
(p = 0.0041), and by contact application and infected (FPC)
(2.8  1010 bacteria/digestive tract) (p = 0.0021) (Fig. 1).
3.6. Physalin B and antibacterial activity
The bacteria growth after incubation of gut extracts for 11 h at
37 C, with hourly turbidimetric readings showed that the largest
difference among groups was encountered after four hours of incu-
bation. This time point was also considered the best to compare
differences among groups in a recent research by Castro et al.
(2012). Insects that received physalin B orally (F), topically (FT)
and by contact (FP) had signiﬁcantly higher antibacterial activity
0.12 (±0.0091), 0.11 (±0.0093) and 0.09 (±0.0093), respectively, inTable 1
Effects of different physalin B applications on parasite infections in R. prolixus 5th-
instar nymphs. Samples of digestive tract 8 days after treatment with physalin B and
challenge by T. cruzi Dm28c clone. CC – insects treated with solvent and infected with
T. cruzi Dm28c clone; FC – insects treated orally with physalin B (1 lg/mL blood) and
infected with T. cruzi Dm28c clone; FTC – insects treated topically with physalin B
(20 ng/insect) and infected with T. cruzi Dm28c clone; FPC – insects treated by contact
with physalin B (57 ng/cm2) and infected with T. cruzi Dm28c clone. Medians were
analyzed with Mann–Whitney test.
Treatments Parasite/mL (range) p value
Control – CC 7.513  104 ± 2.45 –
Oral Physalin – FC 0.87  104 ± 0.49 p < 0.0001
Topical Physalin – FTC 0.30  104 ± 0.20 p < 0.0001
Contact Physalin – FPC 0.70  104 ± 0.30 p = 0.0002
midgut samples collected 9 days after feeding and infection and incubated for 4 h
with E. coli k12 with hourly readings. Treatments: C – control insects fed on blood
and solvent (DMSO); CC – insects treated with solvent and infected with T. cruzi
Dm28c clone; F – insects treated orally with physalin B (1 lg/mL blood); FC –
insects treated orally with physalin B (1 lg/mL blood) and infected with T. cruzi
Dm28c clone; FT – insects treated topically with physalin B (20 ng/insect); FTC –
insects treated topically with physalin B (20 ng/insect) and infected with T. cruzi
Dm28c clone; FP – insects treated by contact with physalin B (57 ng/cm2); FPC –
insects treated by contact with physalin B (57 ng/cm2) and infected with T. cruzi
Dm28c clone. Means were analyzed by using 1 way ANOVA comparing all physalin
groups to the control (C) and all treated and infected to the insects infected (CC),
p < 0.05. Each bar represents mean (±SEM) of four experiments, n = 6–10 insects for
each determination.contrast to control insects (C) with 0.07 (±0.0039) also after 4 h
of incubation (Fig. 2; p < 0.05).
The insects infected with T. cruzi Dm29c clone (CC) had signiﬁ-
cantly higher antibacterial activity (0.089 ± 0.0055) than the
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and treated with physalin B using the topical (FTC) and contact
(FPC) routes presented signiﬁcantly lower antibacterial activity
(0.067 ± 0.0058 and 0.064 ± 0.0054) respectively, than the insects
only infected with the parasites (CC; 0.089 ± 0.0055) (Fig. 2). The
antibacterial activity of the samples from insects treated orally
with physalin B and infected (FC) (0.10 ± 0.0065) did not differ sig-
niﬁcantly from control infected samples (CC) (Fig. 2; p < 0.05).
3.7. Physalin B treatments and nitrite and nitrate production
In these experiments, we observed that insects with physalin B
contact treatment (FP), 3.81 ± 0.14 produced signiﬁcantly less ni-
trite and nitrate, representative of nitric oxide, than the control in-
sects (C) 5.26 ± 0.15 (Fig. 3; p < 0.05).
The insects treated with physalin B using the oral treatment and
infected with parasite (FC) 5.04 ± 0.18 produced signiﬁcantly more
nitrite and nitrate than the control infected insects (CC)
3.61 ± 0.13. The physalin B topical and contact application both in-
fected with the parasite (FTC, 3.42 ± 0.15 and FPC, 3.12 ± 0.15)
caused a similar result of reactive nitrogen species production as
the control infected insects (Fig. 3; p < 0.05).4. Discussion
Previous researches have described immune depression actions
of physalin B in the triatomine vector, R. prolixus. The insects trea-
ted with physalin B and inoculated with E. cloacae b12 and T. ran-
geli had high mortality and low immune responses (Garcia et al.,
2006; Castro et al., 2008). In contrast, the physalin B treatment
(oral, topical and contact application) and infected with T. cruzi
Dm28c clone did not cause any changes in the mortality rate of
the insects. Physalin B effects were involved in controlling the T.
cruzi infection in the vector, modulating the microbiota and gut
immune system of the insect. Physalin B activity on the parasite
infection was investigated not only by oral treatment but also byFig. 3. Nitrite and nitrate production in R. prolixus 5th-instar nymphs treated with
physalin B and challenged by T. cruzi Dm28c clone. Anterior midgut samples
collected 9 days after feeding and infection. Treatments: C – control insects fed on
blood and solvent (DMSO); CC – insects treated with solvent and infected with T.
cruzi Dm28c clone; F – insects treated orally with physalin B (1 lg/mL blood); FC –
insects treated orally with physalin B (1 lg/mL blood) and infected with T. cruzi
Dm28c clone; FT – insects treated topically with physalin B (20 ng/insect); FTC –
insects treated topically with physalin B (20 ng/insect) and infected with T. cruzi
Dm28c clone; FP – insects treated by contact with physalin B (57 ng/cm2); FPC –
insects treated by contact with physalin B (57 ng/cm2) and infected with T. cruzi
Dm28c clone. Bars represent mean ± SEM. Means were analyzed by using 1 way
ANOVA comparing all physalin groups to the control (C) and all treated and infected
to the insects infected (CC), p < 0.05. Each bar represents the mean (±SEM) of four
separate experiment, n = 6–10 insects for each determination.topical and contact applications which indicated the penetration
of the insect cuticle by the compound. Insects treated with physal-
in B did not allow the establishment of the T. cruzi Dm28c clone
infection in the gut during the 8–30 days under observation. More
than 70% of treated and infected insects presented no parasites in
the digestive tract.
The success of the parasite infection in the vector depends on
diverse factors encountered in the insect digestive tract, parasite
strains and insect species (Castro et al., 2012). The parasite T. cruzi
strain Dm28c clone succeeded in infecting R. prolixus by modulat-
ing the microbiota of the insects and their immune response in the
gut (Castro et al., 2012). However, in the insects treated with
physalins the number of parasites, in the entire digestive tract, re-
mains low throughout the period observed. The three different
types of application of physalin (oral, topical and contact) provided
a strong inhibition to the parasite infection.
However in in vitro experiments, the compound doses that had
an immobilization activity over T. cruzi were higher than 350 lg/
mL. This concentration is more than 1000 times higher than the
dose ingested by the insects in the oral treatment (250 ng/mL).
But the physalin B lethal concentration that kills 50% (LC50) of
Plasmodium falciparum was 33.9 lM (Sá et al., 2011). It seems that
T. cruzi is more resistant to physalin B than P. falciparum since the
dose that kills the T. cruzi is much higher than P. falciparum. Thus,
the concentration that lyses these parasites is very high in contrast
to the dose used in the present paper for the treatment of insects,
causing inhibition of parasite infection in the vector. In Leishmania,
physalins B and F were able to reduce the percentage of infected
macrophages (2 lg/mL), and the intracellular parasite number
in vitro at concentrations non-cytotoxic to macrophages
(Guimarães et al., 2009).
After ingestion, T. cruzi usually remains in the gut where it dif-
ferentiates, and then it migrates to the posterior midgut where it
adheres to the perimicrovillar membrane (Gonzalez et al., 1998,
1999). Thus, we analyzed the effects of orally treated insects with
physalin B on the trypanosome adhesion to the perimicrovillar
membrane and did not ﬁnd any signiﬁcant differences when para-
site adhesions were compared with the control. This result demon-
strates that the physalin B mode of action is different from other
compounds, for example, azadirachtin that modiﬁes the mem-
brane structure and which inhibits the parasite adhesion, and con-
sequently decreases the infection in the insect (Nogueira et al.,
1997; Gonzalez et al., 1999).
The success of parasite infection is also dependent on the inter-
action with the insect immune responses and the microbiota of the
insects. Several works have demonstrated that the parasite infec-
tion depends on the microbiota of the insects because it is impor-
tant to maintain the gut homeostasis which gives the insect
resistance to invasion by other microorganisms (Garcia et al.,
2010). We know that the microbiota of Anopheles, Aedes and Rhod-
nius are important for the development and infection of parasites
and viruses (Castro et al., 2012; Cirimotich et al., 2011; Diaz-
Albiter et al., in press; Dong et al., 2009; Walker et al., 2011). Our
recent work with Rhodnius microbiota and T. cruzi demonstrated
that the parasites reduce the bacteria development in the insect
(Castro et al., 2012). In this work the infected insects treated with
physalin B by the oral, topical and contact applications presented
higher microbiota than the control infected insects. Therefore,
the physalin B treatment can result in an increase in bacteria
growth. The normal concentration of microbiota in the insect gut
is responsible for the gut homeostasis, which maintains the insect
immune responses activated and prepared to eliminate parasite
infections (Garcia et al., 2010). Moreover, the microbiota can have
trypanolytic activity, as observed by Serratia marcescens, a bacte-
rium isolated from the gut of R. prolixus with strong lytic effect
on T. cruzi (Azambuja et al., 2004, 2005). Therefore the higher
D.P. Castro et al. / Journal of Insect Physiology 58 (2012) 1620–1625 1625microbiota levels in the gut can affect the T. cruzi survival by try-
panolytic activity or by increasing the immune responses or com-
peting with the parasite for nutrition.
Since physalins induce immune depression in the R. prolixus
hemocele (Castro et al., 2008, 2009; Garcia et al., 2006), and in
mammal cells (Jacobo-Herrera et al., 2006; Soares et al., 2003,
2006; Vandenberghe et al., 2008; Vieira et al., 2005; Yu et al.,
2010), we decided to investigate the immune responses in the in-
sect gut, such as antibacterial activity and production of reactive
nitrogen species. In our experiments, with physalin B topical and
contact applications, the treated insects presented lower antibacte-
rial activity than the infected control insects. One hypothesis is
that the low activity can inﬂuence the bacterial development by
increasing the bacteria load in the gut and reducing the parasite
survival. The physalin B oral application does not alter the antibac-
terial activity but enhances the production of nitrite and nitrate.
The nitrite and nitrate concentrations are products of nitric oxide
degradation, and this immune response seems to be active against
the parasite. So, we hypothesized that the physalin B by oral treat-
ment can enhance the immune response related to reactive nitro-
gen species and therefore regulate the parasite infection in the
insect.
Physalin B has a potent parasite infection inhibition by oral, top-
ical and contact application but their modes of action seem to be
different. While the physalin B topical and contact application acts
by reducing the antibacterial activity, the oral treatment increases
the nitrogen species production. The microbiota is higher in the
three infected forms with physalin B than the infected control
insects.
Physalin B may be an excellent compound to reduce parasite
transmission and control Chagas disease but more investigations
are necessary to elucidate if the physalin inhibits parasite develop-
ment due to alterations in immune responses, or in the microbiota
population or in both of them together.
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